Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2018 Feb;10(2):695-698.
doi: 10.21037/jtd.2018.01.119.

Anti-inflammatory therapy with canakinumab for atherosclerotic disease: lessons from the CANTOS trial

Peter L Thompson  1 , S Mark Nidorf  1
Affiliations
Editorial

Anti-inflammatory therapy with canakinumab for atherosclerotic disease: lessons from the CANTOS trial

Peter L Thompson et al. J Thorac Dis. 2018 Feb.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: Drs. Thompson and Nidorf are Principal Investigators of The LoDoCo2 Trial: Low Dose Colchicine for secondary prevention of cardiovascular disease. ACTRN12614000093684.

Comment on

  • Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.
    Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, Fonseca F, Nicolau J, Koenig W, Anker SD, Kastelein JJP, Cornel JH, Pais P, Pella D, Genest J, Cifkova R, Lorenzatti A, Forster T, Kobalava Z, Vida-Simiti L, Flather M, Shimokawa H, Ogawa H, Dellborg M, Rossi PRF, Troquay RPT, Libby P, Glynn RJ; CANTOS Trial Group. Ridker PM, et al. N Engl J Med. 2017 Sep 21;377(12):1119-1131. doi: 10.1056/NEJMoa1707914. Epub 2017 Aug 27. N Engl J Med. 2017. PMID: 28845751 Clinical Trial.

References

    1. Ross R. Atherosclerosis--an inflammatory disease. N Engl J Med 1999;340:115-26. 10.1056/NEJM199901143400207 - DOI - PubMed
    1. Ridker PM, Lüscher TF. Anti-inflammatory therapies for cardiovascular disease. Eur Heart J 2014;35:1782-91. 10.1093/eurheartj/ehu203 - DOI - PMC - PubMed
    1. Salvo F, Fourrier-Réglat A, Bazin F, et al. Investigators of Safety of Non-Steroidal Anti-Inflammatory Drugs: SOS Project. Cardiovascular and gastrointestinal safety of NSAIDs: a systematic review of meta-analyses of randomized clinical trials. Clin Pharmacol Ther 2011;89:855-66. 10.1038/clpt.2011.45 - DOI - PubMed
    1. STABILITY Investigators , White HD, Held C, et al. Darapladib for preventing ischemic events in stable coronary heart disease. N Engl J Med 2014;370:1702-11. 10.1056/NEJMoa1315878 - DOI - PubMed
    1. Ramiro S, Sepriano A, Chatzidionysiou K, et al. Safety of synthetic and biological DMARDs: a systematic literature review informing the 2016 update of the EULAR recommendations for management of rheumatoid arthritis. Ann Rheum Dis 2017;76:1101-36. 10.1136/annrheumdis-2016-210708 - DOI - PubMed